1185280-74-3

Basic information

• Product Name: 3-(5-(5-cyclopentyl-4H-1,2,4-triazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one
• Synonyms: 3-(5-(5-cyclopentyl-4H-1,2,4-triazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one
• CAS NO: 1185280-74-3
• Molecular Weight: 414.51
• Mol File: 1185280-74-3.mol

Chemical Properties

• CAS DataBase Reference: 3-(5-(5-cyclopentyl-4H-1,2,4-triazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(5-(5-cyclopentyl-4H-1,2,4-triazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one(1185280-74-3)
• EPA Substance Registry System: 3-(5-(5-cyclopentyl-4H-1,2,4-triazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one(1185280-74-3)

Safety Data

• Hazardous Substances Data: 1185280-74-3(Hazardous Substances Data)

Upstream product

• 409082-11-7 2-(2-methyl-5-nitrophenyl)acetonitrile 
• 850451-77-3 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one 
• 22474-47-1 (2-methyl-5-nitro-7-phenyl)methanol 
• 1975-52-6 5-nitro-o-toluic acid 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 
• 850449-93-3 methyl 2-(5-amino-2-methylphenyl)acetate 
• 287119-84-0 2-methyl-5-nitrophenylacetic acid methyl ester 
• 287119-83-9 2-(2-Methyl-5-nitrophenyl)acetic acid 
• 1021535-31-8 3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one 
• 449811-30-7 (6-chloro-4-(methylamino)pyridin-3-yl)methanol 
• 409082-10-6 (2-methyl-5-nitrophenyl)-methyl methylsulfonate 
• 6975-44-6 4,6-dihydroxynicotinic acid ethyl ester 
• 40296-46-6 ethyl 4,6-dichloronicotinate 
• 449811-28-3 ethyl 6-chloro-4-(methylamino)pyridine-3-carboxylate 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS

The invention provides a novel class of compounds of Formula I: (I) pharmaceutical compositions comprising such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFRβ kinases.